PreveCeutical Medical Inc.

PreveCeutical Medical Inc. is a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature identical products.

  • PreveCeutical Provides Update on Sol-gel Drug Delivery Program

    Vancouver, British Columbia--(Newsfile Corp. - July 11, 2018) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to provide an update on the soluble gel ("Sol-gel") drug delivery research and development program (the "Sol-gel Program"), that involves testing an array of cannabis strains ...

    2018-07-11 9:00 AM ET
  • PreveCeutical Retains Link Media LLC to Provide Marketing Services

    Vancouver, British Columbia--(Newsfile Corp. - July 10, 2018) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announced that it has retained Link Media LLC ("Link Media") to provide communications and market awareness services to the Company, aimed at maintaining and building the profile of ...

    2018-07-10 12:05 AM ET
  • PreveCeutical Announces the Closing of Oversubscribed Non-Brokered Private Placement

    Vancouver, British Columbia--(Newsfile Corp. - June 29, 2018) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces the closing of its oversubscribed non-brokered private placement financing previously announced April 9, 2018 (the "Financing").A total of 130,799,750 units (the "Units") were issued under the Financing at ...

    2018-06-29 10:00 AM ET
  • PreveCeutical Announces Oversubscribed Non-Brokered Private Placement

    Vancouver, British Columbia--(Newsfile Corp. - June 25, 2018) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that based on subscriptions received to date, the Company expects that its $4,000,000 non-brokered private placement (the "Offering") of units at $0.05 (post-forward stock split) announced on April ...

    2018-06-25 4:01 PM ET
  • PreveCeutical Amends Terms of Warrants to Extend Expiry Date

    Vancouver, British Columbia--(Newsfile Corp. - June 8, 2018) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that it will be amending the terms of 20,280,000 (4,076,000 pre-forward stock split) common share purchase warrants (each, a "Warrant") previously issued pursuant to a non-brokered ...

    2018-06-08 5:00 PM ET